Hemp + CBD 101
Module 3: Understanding the Endocannabinoid System (ECS)

Lesson 1: The Discovery of the Endocannabinoid System

Complete & Continue Next Lesson Learn More

  • History and Key Milestones in ECS Research:

    The endocannabinoid system (eCS) is a complex regulatory system in the human body that plays a crucial role in maintaining homeostasis. Research into the eCS has revealed its significance in various physiological processes and has led to significant discoveries over the years.

  • Discovery of THC (1964):

    Dr. Raphael Mechoulam, an Israeli chemist, and his team were the first to isolate and synthesize delta-9-tetrahydrocannabinol (THC), the psychoactive compound in cannabis. This discovery laid the foundation for understanding the effects of cannabinoids on the human body.

  • Identification of Cannabinoid Receptors (1988):

    Dr. Allyn Howlett and Dr. William Devane discovered the first cannabinoid receptor, known as CB1, in the brain and central nervous system. This finding provided crucial insights into how cannabinoids interact with the body.

  • Discovery of Anandamide (1992):

    Dr. Raphael Mechoulam and Dr. Lumír Hanuš identified anandamide, an endocannabinoid, in the brain. Anandamide was the first endogenous cannabinoid to be discovered and is involved in various physiological processes.

  • Identification of CB2 Receptors (1993):

    Dr. Sheng-Ming Dai and Dr. Alex Makriyannis identified the CB2 receptor, primarily found in immune cells and peripheral tissues. This discovery expanded our understanding of the ECS's role in immune function.

  • Characterization of the eCS (1990s):

    Researchers began to unravel the ECS's complexity by identifying endocannabinoids like 2-arachidonoylglycerol (2-AG) and studying their functions.

    The ECS was found to consist of receptors (CB1 and CB2), endocannabinoids, and enzymes responsible for their synthesis and degradation.

  • New Recognition of the Role in Homeostasis (2000s): List Item

    Studies emphasized the ECS's role in maintaining homeostasis by regulating various bodily functions, including mood, appetite, pain perception, and immune response.

  • Development of Synthetic Cannabinoids (2000s):

    The development of synthetic cannabinoids, like dronabinol (synthetic THC) and nabilone, expanded therapeutic options for conditions like nausea, vomiting, and appetite loss.

  • Medical Cannabis Research (21st Century):

    Growing interest in medical cannabis and CBD led to research into the ECS's potential therapeutic applications, including pain management, epilepsy, anxiety, and more.

In this Lesson

The Discovery of the Endocannabinoid System

  • Discovery of THC (1964)

  • Identification of Cannabinoid Receptors (1988)

  • Discovery of Anandamide (1992)

  • Identification of CB2 Receptors (1993)

  • Characterization of the ECS (1990s)

  • Recognition of the Role in Homeostasis (2000s)

  • Development of Synthetic Cannabinoids (2000s)

  • Medical Cannabis Research (21st Century)

ANDREW SERAFINI, INSTRUCTOR